SE8703225D0 - Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections - Google Patents

Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections

Info

Publication number
SE8703225D0
SE8703225D0 SE8703225A SE8703225A SE8703225D0 SE 8703225 D0 SE8703225 D0 SE 8703225D0 SE 8703225 A SE8703225 A SE 8703225A SE 8703225 A SE8703225 A SE 8703225A SE 8703225 D0 SE8703225 D0 SE 8703225D0
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
peptides
treating
hiv infections
peptides useful
Prior art date
Application number
SE8703225A
Other languages
English (en)
Other versions
SE8703225L (sv
SE506025C2 (sv
Inventor
M K Shriver
E K Thomas
W L Oosand
L H Gosting
E S Dickinson
J N M I Mcclure
G J Todaro
R C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8703225D0 publication Critical patent/SE8703225D0/sv
Publication of SE8703225L publication Critical patent/SE8703225L/sv
Publication of SE506025C2 publication Critical patent/SE506025C2/sv

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8703225A 1986-08-20 1987-08-19 Monoklonala antikroppar och peptider samt beredningar av dessa för behandling och diagnos av HIV-infektion jämte cellinjer för antikroppsframställning SE506025C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
SE8703225D0 true SE8703225D0 (sv) 1987-08-19
SE8703225L SE8703225L (sv) 1988-02-21
SE506025C2 SE506025C2 (sv) 1997-11-03

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703225A SE506025C2 (sv) 1986-08-20 1987-08-19 Monoklonala antikroppar och peptider samt beredningar av dessa för behandling och diagnos av HIV-infektion jämte cellinjer för antikroppsframställning

Country Status (28)

Country Link
JP (1) JPS6485928A (sv)
KR (1) KR920008744B1 (sv)
AT (1) AT398080B (sv)
AU (1) AU616156B2 (sv)
BE (1) BE1000811A4 (sv)
CH (1) CH675728A5 (sv)
CS (1) CS275838B6 (sv)
DE (1) DE3727703A1 (sv)
DK (1) DK433087A (sv)
ES (1) ES2010727A6 (sv)
FI (1) FI873553A (sv)
FR (1) FR2603107B1 (sv)
GB (1) GB2196634B (sv)
GR (1) GR871298B (sv)
HU (1) HU214439B (sv)
IE (1) IE60671B1 (sv)
IL (1) IL83580A (sv)
IT (1) IT1222518B (sv)
LU (1) LU86972A1 (sv)
NL (1) NL8701950A (sv)
NO (2) NO300462B1 (sv)
NZ (1) NZ221440A (sv)
OA (1) OA08652A (sv)
PL (1) PL155084B1 (sv)
PT (1) PT85567B (sv)
SE (1) SE506025C2 (sv)
YU (1) YU152587A (sv)
ZW (1) ZW15487A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
JP2569185B2 (ja) * 1988-01-26 1997-01-08 アメリカ合衆国 抗ｈｉｖ応答を喚起する合成抗原
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
JPH04502760A (ja) * 1988-10-03 1992-05-21 レプリゲン・コーポレーション エイズの診断，予防および治療に有効な新規ｈｉｖ蛋白質およびペプチド
CA2025481A1 (en) * 1989-09-19 1991-03-20 Peter J. Kniskern Vaccine for aids and hepatitis b
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
DE69333537T2 (de) * 1992-03-27 2005-06-16 Advanced Immuni T, Inc. T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose
CA2952475C (en) 2005-12-09 2022-08-09 Vectus Biosystems Limited Vip fragment for the treatment of myocardial fibrosis
KR101215215B1 (ko) 2008-09-02 2012-12-24 니혼도꾸슈도교 가부시키가이샤 스파크 플러그

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE122005000039I1 (de) * 1984-10-18 2006-02-23 Pasteur Institut DNS-Fragmente des GAG-Gens von LAV
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
JP2837669B2 (ja) * 1985-11-07 1998-12-16 プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ Ｔ−細胞リンパ趨行性ウイルス蛋白及びその分析
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド

Also Published As

Publication number Publication date
KR920008744B1 (ko) 1992-10-09
NO934897D0 (no) 1993-12-29
FI873553A0 (fi) 1987-08-17
CS8706136A2 (en) 1990-08-14
KR890002547A (ko) 1989-04-10
OA08652A (fr) 1988-11-30
NO302176B1 (no) 1998-02-02
FR2603107A1 (fr) 1988-02-26
ATA208987A (de) 1994-01-15
GR871298B (en) 1988-01-12
NO873495L (no) 1988-02-22
IL83580A (en) 1992-11-15
BE1000811A4 (fr) 1989-04-11
GB2196634A (en) 1988-05-05
JPS6485928A (en) 1989-03-30
LU86972A1 (fr) 1988-03-02
IT8721678A0 (it) 1987-08-19
PT85567A (en) 1987-09-01
AT398080B (de) 1994-09-26
SE8703225L (sv) 1988-02-21
NO300462B1 (no) 1997-06-02
FI873553A (fi) 1988-02-21
DK433087D0 (da) 1987-08-19
IE872219L (en) 1988-02-20
NZ221440A (en) 1991-11-26
ZW15487A1 (en) 1988-09-14
NL8701950A (nl) 1988-03-16
IE60671B1 (en) 1994-08-10
NO873495D0 (no) 1987-08-19
CH675728A5 (sv) 1990-10-31
PL267401A1 (en) 1988-07-21
DE3727703A1 (de) 1988-05-05
CS275838B6 (en) 1992-03-18
AU616156B2 (en) 1991-10-24
IL83580A0 (en) 1988-01-31
PT85567B (pt) 1991-02-08
ES2010727A6 (es) 1989-12-01
NO934897L (no) 1993-12-29
YU152587A (sh) 1992-09-07
IT1222518B (it) 1990-09-05
HUT44619A (en) 1988-03-28
AU7720187A (en) 1988-05-19
HU214439B (hu) 1998-03-30
GB8719587D0 (en) 1987-09-23
SE506025C2 (sv) 1997-11-03
PL155084B1 (en) 1991-10-31
FR2603107B1 (fr) 1992-04-24
DK433087A (da) 1988-02-21
GB2196634B (en) 1991-05-15

Similar Documents

Publication Publication Date Title
SE8703225D0 (sv) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
ATE294864T1 (de) Äusseres membranprotein von haemophilus
DE3751751T2 (de) Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
ES8801319A1 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
ATE122237T1 (de) Hiv-1 neutralisierende monoklonale antikörper.
DK442788D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
ATE96033T1 (de) Mittel zur behandlung von arthrosen.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
Salton et al. Subunit structure and properties of two forms of adenosine triphosphatase released from Micrococcus, lysodeikticus membranes
FR2669338B1 (sv)
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DE3854550D1 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
BG99074A (en) Recombinant human hiv neutralizing monoclonal antibodies for prophylaxy and treatment of hiv infection
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
EP0270114A3 (de) ENV/GAG-Polypeptide
NO962596L (no) Nytt tumorsupressorgen
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8703225-6

Format of ref document f/p: F